InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Kaiser Peter. Director active across 1 company, notably Ocular Therapeutix, INC. Cumulatively, 3 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €45k. Activity tracked since 2 October 2024. The latest transaction was disclosed on 24 February 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations